Delivery

| CRISPR Medicine | This is an overview of articles on delivery

Sign-up to weekly Newsletter here.

Andre Watson Shares What's Missing from the Gene...

Feb. 22, 2021

Andre Watson, the founder of the gene delivery platform company Ligandal, quickly pivoted his company to develop a therapeutic for COVID-19. But he...

Antibody-Targeted Lipid Nanoparticles Reach High...

Dec. 14, 2020

Lack of efficient delivery vehicles has so far hampered CRISPR-Cas9 editing in non-liver tumours. With a new lipid nanoparticle delivery system,...

CRISPR Medicine News Interview with Scribe...

Oct. 19, 2020

California-based gene-editing company Scribe Therapeutics recently unveiled its plans to develop the most advanced platform for breakthrough...

Tuneable, Biodegradable, Lipid-Like Nanoparticles...

Sep. 22, 2020

All gene therapies have their own advantages and limitations, but one shared feature is the challenge in delivering the gene-editing or replacement...

Explainer: DNA, RNA or Protein: Which Format Is...

Aug. 24, 2020

For CRISPR genome editing, it is important to consider what form the agent is delivered. In this explainer, we look at the different forms (plasmid...

Curing hereditary blindness with CRISPR-Cas...

Aug. 20, 2020

Using 'dead' dCas9 fused to transcriptional activators researchers wake silent genes to alleviate blindness in a mouse model of retinitis pigmentosa -...

Tiny but Mighty: How Researchers Found a New...

Aug. 4, 2020

Researchers at UC Berkeley have discovered CasΦ, a small and highly compact CRISPR system in bacteriophages. The new CasΦ works in human cells and...

Catching up on CRISPR Delivery Methods

Jul. 21, 2020

The first clinical trial results indicate that CRISPR is a safe and beneficial gene editing tool in humans. However, full therapeutic translation of...